rttnews.com

Biotech Stocks Facing FDA Decision In March 2025

March is recognized as Awareness Month for several diseases, including Colorectal Cancer, Cerebral Palsy, Deep Vein Thrombosis, Endometriosis, Essential Tremor, Kidney Cancer, Multiple Sclerosis, and others.

The FDA has approved five novel drugs so far this year. Now, let's take a look at the biotech stocks facing FDA decisions in March 2025.

For comments and feedback contact: editorial@rttnews.com

Business News

Slide Shows

Read full news in source page